Mauna Kea Technologies SA Act. Categorie -O- 1MK
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €0.10
- Day Range
- €0.10–0.10
- 52-Week Range
- —–—
- Bid/Ask
- €0.11 / €0.12
- Shares Outstanding
- 198.63M
- Market Cap
- €20.06M
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 1.20
- Price/Sales
- 2.07
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Mauna Kea Technologies SA is a medical device company that develops, manufactures and markets an imaging platform for visualizing tissue at the cellular level, in real time, during standard procedures, with the mission of eliminating uncertainties in diagnosis and treatment through direct visualization of tissue in vivo at the microscopic level. The company's flagship product, Cellvizio, is the smallest microscope, designed for direct use during minimally invasive procedures. It operates in a single business segment: endomicroscopy. Its geographical presence includes EMEA (Europe, Middle East, Africa), USA and Canada, and Asia, of which the majority of the revenue is generated from USA and Canada.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 59
- Website
- https://www.maunakeatech.com
Valuation
|
Metric
|
1MK
|
|---|---|
Price/Earnings (Normalized) | 1.20 |
Price/Book Value | — |
Price/Sales | 2.07 |
Price/Cash Flow | — |
Price/Earnings
1MK
Financial Strength
|
Metric
|
1MK
|
|---|---|
Quick Ratio | 0.92 |
Current Ratio | 1.46 |
Interest Coverage | −9.36 |
Quick Ratio
1MK
Profitability
|
Metric
|
1MK
|
|---|---|
Return on Assets (Normalized) | 94.01% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −66.60% |
Return on Assets
1MK
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|@yzpL< | LOCK|LWBKZ | $176B | |||
| Medtronic PLC
MDT
| LOCK|%#m>$^ | LOCK|>%Y&H | $118B | |||
| Stryker Corp
SYK
| LOCK|zxn^vkdS | LOCK|>j> | $108B | |||
| Boston Scientific Corp
BSX
| LOCK|JD%q^W | LOCK|@fCW | $64B | |||
| Edwards Lifesciences Corp
EW
| LOCK|NDx<ZZ! | LOCK|yFCF# | $50B | |||
| DexCom Inc
DXCM
| LOCK|QH#g@TY | LOCK|<!@X | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|<NR#FW | LOCK|M$ | $31B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|Fx | LOCK|!z | $24B | |||
| Steris PLC
STE
| LOCK|J^C^^^ | LOCK|Zv%M? | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|$!@b&&YT | LOCK|Bb@ | $18B |
United States